Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do
eiusmod tempor
incididunt ut labore et dolore magna aliqua.
About Us
“WE AIM TO CHANGE LIVES BY DELIVERING BREAKTHROUGH INNOVATIONS IN INFECTIOUS DISEASE DIAGNOSTICS” - Dr. Anmol S. Kapoor, CEO
BioAro is a leading developer of Point of Care (POC) medical diagnostic platform technologies that will transform healthcare worldwide. The company has developed an electrochemical bio-sensing based technology platform, which it is using to develop POC rapid diagnostic tests for Covid-19 & working on developing other diagnostic platforms for infectious diseases in humans, poultry, fisheries and animals.
Infectious Diseases
Infectious diseases are caused when a pathogen (such as bacteria, viruses, fungi, parasites) enters the body. They can spread directly from one person to another (via skin contact) or indirectly (via contaminated food or water).
229 million cases of malaria worldwide in 2019
236 million cases of sexually transmitted infections (syphilis, gonorrhea, chlamydia and trichomonas each year.
38.0 million people living with HIV/AIDS at the end of 2019.
10 million people fell ill, and 1.4 million people died from tuberculosis worldwide in 2019(including 208,000 with HIV).
SARS Cov-2 Global Challenge
COVID-19 is a SARS-Cov-2 virus that has caused respiratory viral infection that has created a pandemic. The pandemic has brought life to a standstill life in every part of the world. It has Spread rapidly across communities affecting all races, ages and genders, however, people who have underlying medical conditions and those over 60 years old have a higher risk of developing severe disease and possible death.
As of Jan 5, 2021;
- 1.8 million deaths.
- 83 million confirmed cases.
- 997.35 million test has been performed.
Current diagnostic techniques such as Immunological or molecular-based assays including nucleic acid hybridization and polymerase chain reaction (PCR) are time-consuming and require centralized laboratories, experienced personnel and large equipment.
BioAro will overcome the need for Rapid point-of-care diagnostics, High throughput / Scale-up testing, Advanced patient care platforms (Virtual Care, Health monitoring tools) and many more.
BioAro
BioAro is a leading developer of Point of Care (POC) medical diagnostic platform technologies that will transform healthcare worldwide. We have developed an electrochemical bio-sensing based technology platform that is being utilized in the development of Covid-19 testing platforms. We are using the same platform for the development of other diagnostic platforms for infectious diseases in humans, poultry, fisheries and animals. Our Covid-19 testing platform allows us to provide rapid diagnostic laboratory testing while maintaining high sensitivity and specificity.
Technology
CoviAro™
CoviLamp™
CoviLamp™ (SARS-CoV-2 Screening Assay Kit), the viral RNA can be detected in less than 30 minutes depending upon the viral load criteria of the individual lab. CoviLamp™ can be performed without the need of expensive specialized equipment and requires minimal training.
BioAro - Pipeline
LAMP Covid-19 Diagnostic test launch (Currently being used in Calgary, CA) CoviAro Mobile Application Launch (*Already being used in India).
Coviaro POC Diagnostic Kit for Covid-19 and Lateral Flow Assay launch
POC Diagnostic kit launch for Virology infections like HIV/AIDS, Flu (Influenza) Hepatitis etc; tuberculosis and STIs (Sexually transmitted Infections) like syphilis, gonorrhea, chlamydia and trichomonas.
POC Diagnostic kit for zoonotic Infectious diseases
POC Diagnostic kit launch for other infection in humans like Malaria & Cholera.
